For The Better

A big earnings beat, a dividend raise, and price target increases from analysts…what wasn’t to like about the company’s latest news?

There’s nothing like the combination of a winning quarter and a substantial analyst price target hike.

Investors did not warmly greet the latest news from the biotech.

Investors did not warmly greet the latest news from the biotech.

The cancer diagnostic company saw its shares take a big jump for the second straight week.

The cancer diagnostic company saw its shares take a big jump for the second straight week.

There’s a trust issue when it comes to Energy Transfer, but if you can look past that, the business is performing well.

There’s a trust issue when it comes to Energy Transfer, but if you can look past that, the business is performing well.

Two ostensibly bullish analysts knock the company with faint praise.

Two ostensibly bullish analysts knock the company with faint praise.

Tesla plans to mass produce a robotaxi in 2024, and Ark Invest believes the stock could grow at an explosive pace in the following years.

Home Depot and Target might have disappointed in their earnings report this week, but they’re still long-term buys.